Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate
- PMID: 30993464
- DOI: 10.1208/s12249-019-1372-5
Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate
Abstract
A promising approach to achieve a more efficient antitumor therapy is the conjugation of the active molecule to a nanostructured delivery system. Therefore, the main objective of this research was to prepare nanoparticles (NPs), with the polymer poly (ε-caprolactone) (PCL), as a carrier for the antitumor drug methotrexate (MTX). A pH-responsive behavior was obtained through conjugation of the amino acid-based amphiphile, 77KL, to the NP matrix. The NPs showed mean hydrodynamic diameter and drug entrapment efficiency of 178.5 nm and 20.52%, respectively. Owing to its pH-sensitivity, the PCL-NPs showed membrane-lytic behavior upon reducing the pH value of surrounding media to 5.4, which is characteristic of the endosomal compartments. The in vitro antitumor assays demonstrated that MTX-loaded PCL-NPs have higher antiproliferative activity than free drug in MCF-7 cells and, to a lesser extent, in HepG2 cells. This same behavior was also achieved at mildly acidic conditions, characteristic of the tumor microenvironment. Altogether, the results evidenced the pH-responsive properties of the designed NPs, as well as the higher in vitro cytotoxicity compared to free MTX, representing thus a promising alternative for the antitumor therapy.
Keywords: cancer; in vitro cell models; lysine-based surfactant; pH-responsive nanoparticles; poloxamer.
Similar articles
-
In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.Biomaterials. 2013 Apr;34(11):2758-72. doi: 10.1016/j.biomaterials.2013.01.005. Epub 2013 Jan 24. Biomaterials. 2013. PMID: 23352041
-
Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.Amino Acids. 2016 Jan;48(1):157-68. doi: 10.1007/s00726-015-2075-1. Epub 2015 Aug 26. Amino Acids. 2016. PMID: 26306845
-
Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.Pharm Dev Technol. 2019 Jan;24(1):89-98. doi: 10.1080/10837450.2018.1425433. Epub 2018 Jan 18. Pharm Dev Technol. 2019. PMID: 29307260
-
Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.Colloids Surf B Biointerfaces. 2016 Nov 1;147:326-335. doi: 10.1016/j.colsurfb.2016.08.014. Epub 2016 Aug 12. Colloids Surf B Biointerfaces. 2016. PMID: 27543694
-
pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review.Nanomaterials (Basel). 2020 Aug 17;10(8):1613. doi: 10.3390/nano10081613. Nanomaterials (Basel). 2020. PMID: 32824578 Free PMC article. Review.
Cited by
-
Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy.Drug Des Devel Ther. 2022 Dec 5;16:4139-4149. doi: 10.2147/DDDT.S386100. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36506793 Free PMC article.
-
Hydrogels for Antitumor and Antibacterial Therapy.Gels. 2022 May 19;8(5):315. doi: 10.3390/gels8050315. Gels. 2022. PMID: 35621613 Free PMC article. Review.
-
Glycyrrhetinic acid modified and pH-sensitive mixed micelles improve the anticancer effect of curcumin in hepatoma carcinoma cells.RSC Adv. 2019 Dec 3;9(68):40131-40145. doi: 10.1039/c9ra07250k. eCollection 2019 Dec 2. RSC Adv. 2019. PMID: 35541419 Free PMC article.
-
Overcoming MDR by Associating Doxorubicin and pH-Sensitive PLGA Nanoparticles Containing a Novel Organoselenium Compound-An In Vitro Study.Pharmaceutics. 2021 Dec 29;14(1):80. doi: 10.3390/pharmaceutics14010080. Pharmaceutics. 2021. PMID: 35056975 Free PMC article.
-
Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.Drug Des Devel Ther. 2020 Feb 26;14:823-832. doi: 10.2147/DDDT.S235098. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32161442 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous